Skip to main content

Table 2 Systemic and local therapy of patients participated in the QoL study

From: Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial

 

Arm A

Surgical therapy

N=37

Arm B

No surgical therapy

N=42

p*

 

N (%)

N (%)

 

First line therapy

 Any CTX no Taxane

6 (16.2)

5 (11.9)

 

 Any CTX with Taxane

4 (10.8)

10 (23.8)

 

 Endocrine therapy

27 (73.0)

27 (64.3)

0.308

Radiotehrapy

 Breast/Chest wall

9 (22.0)

2 (4.7)

0.020

 Metastases

11(26.8)

8 (18.6)

0.268

Surgery

 Metastases

1 (2.4)

3 (7.0)

0.618

  1. *Fischer exact test
  2. CTX-Chemotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us